Taking Control: Emerging Issues in Pain ... - Pharmacy Times
Taking Control: Emerging Issues in Pain ... - Pharmacy Times
Taking Control: Emerging Issues in Pain ... - Pharmacy Times
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Assessment of Addiction Risk<br />
• Screen<strong>in</strong>g measures for addiction risk:<br />
• STAR/SISAP<br />
• CAGE AIDD<br />
• Opioid Risk Tool (<strong>Emerg<strong>in</strong>g</strong> Solutions <strong>in</strong> Pa<strong>in</strong>)<br />
• SOAPP (see pa<strong>in</strong>edu.org)<br />
• Psychiatric assessment of risk:<br />
• Chemical<br />
• Psychiatric<br />
• Social/Familial<br />
• Genetic<br />
• Spiritual<br />
Position<strong>in</strong>g Opioid Therapy<br />
Opioid Risk Tool<br />
Mark each box that applies. Female Male<br />
1. Family history of substance abuse<br />
– Alcohol<br />
– Illegal drugs<br />
– Prescrib<strong>in</strong>g drugs<br />
2. Personal history of substance abuse<br />
– Alcohol<br />
– Illegal drugs<br />
– Prescrib<strong>in</strong>g drugs<br />
1<br />
2<br />
4<br />
3<br />
4<br />
5<br />
3<br />
3<br />
4<br />
3<br />
4<br />
5<br />
3. Age (mark box if 16-45 years) 1 1<br />
4. History of preadolescent sexual abuse 3 0<br />
5. Psychological disease<br />
– Attention deficit disorder, obsessive compulsive<br />
disorder, bipolar, schizophrenia<br />
– Depression<br />
Scor<strong>in</strong>g: 0-3: low risk; 4-7: moderate risk; ≥8: high risk<br />
2<br />
1<br />
2<br />
1<br />
Webster LR, Webster RM. Pa<strong>in</strong> Med. 2005;6:432-442.<br />
♦No past/current<br />
history of<br />
substance abuse<br />
♦Noncontributory<br />
family history of<br />
substance abuse<br />
♦No major or untreated<br />
psychological<br />
disorder<br />
Stratify Risk<br />
Low Risk Moderate Risk High Risk<br />
♦Significant family<br />
history of<br />
substance abuse<br />
♦Past/co-morbid<br />
psychological<br />
disorder<br />
♦History of treated<br />
substance abuse<br />
♦Active substance<br />
abuse<br />
♦Active addiction<br />
♦Major untreated<br />
psychological<br />
disorder<br />
♦Significant risk<br />
to self and<br />
practitioner<br />
Current Opioid Misuse Measure<br />
(COMM)<br />
• 17-item patient self-assessment : for those<br />
currently on long-term opioid therapy<br />
• S/S <strong>in</strong>toxication, emotional volatility, poor<br />
response to medications, addiction, healthcare<br />
use patterns, problematic medication behavior<br />
• NOT used prior to therapy<br />
Gourlay DL, et al. Pa<strong>in</strong> Med. 2005;6:107-112.<br />
Meltzer et al. Pa<strong>in</strong>. 2011;152:397-402.<br />
Risk Factors for Aberrant<br />
Behaviors/Harm<br />
Restructur<strong>in</strong>g Therapy<br />
to Reduce Risk<br />
Biological<br />
• Age ≤ 45 years<br />
• Gender<br />
• Family history of<br />
prescription drug<br />
or alcohol abuse<br />
• Cigarette smok<strong>in</strong>g<br />
Psychiatric<br />
• Preadolescent sexual<br />
abuse (<strong>in</strong> women)<br />
• Major psychiatric<br />
disorder (eg, personality<br />
disorder, anxiety or<br />
depressive disorder,<br />
bipolar disorder)<br />
• Substance use disorder<br />
Social<br />
• Prior legal problems<br />
• History of motor<br />
vehicle accidents<br />
• Poor family support<br />
• Involvement <strong>in</strong> a<br />
problematic<br />
subculture<br />
• Consider discont<strong>in</strong>uation of opioid<br />
• Cont<strong>in</strong>ue opioid but consider reactive strategies to<br />
improve control over drug use:<br />
• Written agreement (“contract”)<br />
• Frequent visits, small quantities<br />
• Long-act<strong>in</strong>g drugs with no rescue doses<br />
• One pharmacy, pill counts, no replacements<br />
or early scripts<br />
• Ur<strong>in</strong>e drug screens<br />
• Required referrals<br />
Katz NP, et al. Cl<strong>in</strong> J Pa<strong>in</strong>. 2007;23:103-118; Manchikanti L, et al. J Opioid Manage. 2007;3:89-100. Webster LR,<br />
Webster RM. Pa<strong>in</strong> Med. 2005;6:432-442.